Table 1.
Characteristics of Study Sample and Subsamples of Individuals Aged 30 to 79 Years
| Characteristic | Overall Sample | Coronary Artery Disease | Diabetes and Aged >40 Years | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Total | On Statin | Not on Statin | Total | On Statin | Not on Statin | Total | On Statin | Not on Statin | |
| Individuals, No. | 16,712 | 2,799 | 13,913 | 1,304 | 694 | 608 | 2,016 | 992 | 1,019 |
| Weighted proportion, % | – | 18.8 (18.0–19.7) |
81.2 (80.3–82.0) |
– | 58.2 (54.6–61.7) |
41.8 (38.3–45.4) |
– | 52.0 (49.4–54.6) |
48.0 (45.4–50.6) |
| Population in millions, No. | 166 (159–173) |
31.2 (29.2–33.2) |
135 (129–140) |
13.4 (12.3–14.5) |
7.8 (7.0–8.6) |
5.6 (4.9–6.3) |
18.7 (17.3–20.0) |
9.7 (8.9–10.6) |
9.0 (8.2–9.8) |
| Age, y | 51.3 (51.0–51.6) |
61.1 (60.6–61.6)a |
49.0 (48.7–49.3)a |
62.9 (62.3–63.6) |
64.9 (64.1–65.7)a |
60.2 (59.1–61.4)a |
60.3 (59.6–60.9) |
61.8 (61.1–62.6)a |
58.5 (57.6–59.4)a |
| Sex, female, % | 50.8 (50.2–51.4) |
46.7 (44.8–48.7)b |
51.7 (50.9–52.5)b |
41.4 (38.4–44.5) |
37.8 (33.6–42.3)b |
46.4 (41.9–51.1)b |
49.3 (46.8–51.8) |
49.8 (46.0–53.6) |
48.8 (44.8–52.8) |
| Tobacco users, % | 18.6 (17.7–19.5) |
16.4 (14.8–18.2)b |
19.1 (18.1–20.1)b |
21.7 (18.5–25.3) |
19.7 (15.9–24.0)b |
24.7 (20.5–29.4)b |
17.0 (15.1–19.0) |
15.7 (13.4–18.4) |
18.3 (15.5–21.5) |
| Hypertension, % | 39.2 (38.1–40.3) |
70.7 (68.2–72.7)b |
31.9 (30.8–33.1)b |
80.3 (77.6–82.8) |
84.2 (80.6–87.4)b |
74.8 (70.7–78.5)b |
81.1 (78.8–83.1) |
86.0 (83.1–88.6)b |
75.7 (72.1–78.9)b |
| Hyperlipidemia, % | 38.4 (37.5–39.3) |
95.8 (94.8–96.6)b |
25.1 (24.3–26.0)b |
78.7 (76.2–81.1) |
94.3 (92.0–96.0)b |
57.1 (52.7–61.4)b |
77.4 (75.0–79.5) |
94.8 (92.7–96.3)b |
58.5 (54.7–62.3)b |
| Race/ethnicity, % | |||||||||
| White | 69.5 (67.6–71.3) |
77.8 (76.0–80.3)b |
67.5 (65.5–69.5)b |
74.9 (71.8–77.7) |
80.3 (76.7–83.4)b |
67.3 (62.1–72.1)b |
62.8 (59.4–66.1) |
67.3 (63.3–71.0)b |
58.0 (53.3–62.5)b |
| Black | 11.2 (10.1–12.5) |
9.4 (8.0–11.0) |
11.6 (10.4–13.0) |
11.5 (9.6–13.6) |
9.1 (6.9–12.1) |
14.8 (11.9–18.2) |
16.4 (14.0–19.0) |
14.4 (11.9–17.4) |
18.4 (15.2–21.5) |
| Hispanic | 12.8 (11.4–14.3) |
7.2 (6.1–8.5) |
14.1 (12.6–15.8) |
8.2 (6.4–10.5) |
5.4 (4.0–7.3) |
12.2 (8.9–16.3) |
13.0 (11.0–15.3) |
10.2 (8.1–12.7) |
16.9 (14.0–22.2) |
| Asian | 4.7 (3.9–5.6) |
3.6 (2.6–4.9) |
4.9 (4.2–5.9) |
2.7 (1.8–4.0) |
3.2 (2.1–4.9) |
1.9 (1.0–3.7) |
4.4 (3.4–5.7) |
4.9 (3.5–6.7) |
3.9 (2.8–5.5) |
| Other | 1.8 (1.4–2.3) |
2.0 (1.3–3.0) |
1.8 (1.4–2.2) |
2.7 (1.8–4.2) |
1.9 (1.0–3.8) |
3.9 (2.3–6.3) |
3.5 (2.4–4.8) |
3.2 (2.1–4.9) |
3.7 (2.4–5.8) |
| Insurance, % | |||||||||
| Any private | 70.7 (67.6–72.0) |
69.9 (67.4–72.3)b |
70.9 (69.5–72.3)b |
55.1 (51.3–58.9) |
59.7 (55.0–64.1)b |
48.8 (43.5–54.1)b |
60.6 (57.8–63.3) |
62.2 (58.4–65.9)b |
58.8 (54.9–62.6)b |
| Public | 15.6 (14.7–16.6) |
25.7 (23.6–27.9) |
13.3 (12.4–14.3) |
37.3 (34.0–40.8) |
35.8 (31.7–40.1) |
39.4 (34.9–44.2) |
30.5 (27.9–33.3) |
32.5 (29.2–36.0) |
28.4 (24.7–32.4) |
| None | 13.7 (12.8–14.6) |
4.4 (3.6–5.5) |
15.8 (14.8–16.9) |
7.6 (6.1–9.3) |
4.5 (3.1–6.7) |
11.8 (9.1–15.1) |
8.9 (7.5–10.6) |
5.3 (3.6–7.7) |
12.8 (10.7–15.3) |
Note: Values are mean (95% CI) or percentage (95% CI).
a
Difference between those on a statin and not on a statin was significant (P <.05) with the adjusted Wald test.
b
Difference between those on a statin and not on a statin was significant (P <.05) with the χ2 test.